FIBROBLAST GROWTH FACTOR RECEPTOR 3 REGULATES THE ACTIVITY OF PROFIBROTIC CYTOKINE AND GROWTH FACTOR PATHWAYS TO DRIVE FIBROBLAST ACTIVATION AND TISSUE FIBROSIS IN SYSTEMIC SCLEROSIS

Chakraborty D, Zhu H, Juengel A, Summa L, Li YN, Bergmann C, Matei AE, Trinh-Minh T, Chen CW, Dees C, Ramming A, Schett G, Distler O, Distler J (2020)

Publication Type: Conference contribution

Publication year: 2020

Journal

Annals of the Rheumatic Diseases BMJ Publishing Group

Publisher: BMJ PUBLISHING GROUP

City/Town: LONDON

Pages Range: 91-91

Conference Proceedings Title: ANNALS OF THE RHEUMATIC DISEASES

DOI: 10.1136/annrheumdis-2020-eular.2915

Authors with CRIS profile

Debomita Chakraborty Department of Medicine 3 – Rheumatology and Immunology Alexandru-Emil Matei Department of Medicine 3 – Rheumatology and Immunology Clara Dees Department of Medicine 3 – Rheumatology and Immunology Andreas Ramming Medizinische Fakultät Georg Schett Lehrstuhl für Innere Medizin III Jörg Distler Professur für Molekulare Mechanismen der Organfibrose

Involved external institutions

University of Zurich / Universität Zürich (UZH) CH Switzerland (CH)

How to cite

APA:

Chakraborty, D., Zhu, H., Juengel, A., Summa, L., Li, Y.N., Bergmann, C.,... Distler, J. (2020). FIBROBLAST GROWTH FACTOR RECEPTOR 3 REGULATES THE ACTIVITY OF PROFIBROTIC CYTOKINE AND GROWTH FACTOR PATHWAYS TO DRIVE FIBROBLAST ACTIVATION AND TISSUE FIBROSIS IN SYSTEMIC SCLEROSIS. In ANNALS OF THE RHEUMATIC DISEASES (pp. 91-91). LONDON: BMJ PUBLISHING GROUP.

MLA:

Chakraborty, Debomita, et al. "FIBROBLAST GROWTH FACTOR RECEPTOR 3 REGULATES THE ACTIVITY OF PROFIBROTIC CYTOKINE AND GROWTH FACTOR PATHWAYS TO DRIVE FIBROBLAST ACTIVATION AND TISSUE FIBROSIS IN SYSTEMIC SCLEROSIS." Proceedings of the Annual European Congress of Rheumatology (EULAR) LONDON: BMJ PUBLISHING GROUP, 2020. 91-91.

BibTeX: Download